Immune effector cell-associated neurotoxicity syndrome, grade 5 digital illustration

Immune effector cell-associated neurotoxicity syndrome, grade 5 Save


ICD-10 code: G92.05

Disease category: None

Understanding Immune Effector Cell-Associated Neurotoxicity Syndrome, Grade 5

Immune effector cell-associated neurotoxicity syndrome (ICANS) is a serious side effect of certain cancer treatments that involve immunotherapy. ICANS is a neurological disorder that affects the brain and can lead to various symptoms, including seizures, confusion, and loss of consciousness.

ICANS is classified into different grades based on the severity of symptoms, with grade 5 being the most severe. Grade 5 ICANS is a life-threatening condition that requires immediate medical attention.

Symptoms of Grade 5 ICANS

The symptoms of grade 5 ICANS can vary depending on the individual. However, some common symptoms include:

  1. Severe confusion or delirium
  2. Coma
  3. Seizures
  4. Loss of consciousness
  5. Difficulty speaking or understanding speech
  6. Difficulty with movement or coordination

It is important to note that not all patients will experience all of these symptoms, and some patients may experience additional symptoms not listed here.

Causes of Grade 5 ICANS

Grade 5 ICANS is caused by an overactive immune response triggered by certain cancer treatments that involve immunotherapy. Immunotherapy is a type of cancer treatment that uses the body's own immune system to fight cancer cells.

However, in some cases, the immune system can become overactive and attack healthy cells in the body, including those in the brain. This can lead to the development of ICANS, including grade 5 ICANS.

Conclusion

Overall, grade 5 ICANS is a serious condition that requires immediate medical attention. It is important for patients undergoing immunotherapy to be aware of the symptoms of ICANS and to report any unusual symptoms to their healthcare provider right away.

Treatment of Immune effector cell-associated neurotoxicity syndrome, grade 5:

Treatment Options for Immune Effector Cell-Associated Neurotoxicity Syndrome Grade 5
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a severe complication that can occur after treatment with chimeric antigen receptor (CAR) T-cell therapy. ICANS can range from mild to severe, with grade 5 being the most severe form of the syndrome. It is essential to understand the tr...

To see full information about treatment please Sign up or Log in